OncoSec Medical Incorporated (ONCS) Stock Analyst Earnings Estimates
NASDAQ:ONCS - Nasdaq - US68234L4059 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | ||||||||||
| EBITDA YoY % growth | -11.17M | -20.58M -84.24% | -26.53M -28.91% | -21.07M 20.58% | -35.77M -69.77% | -30.18M 15.63% | -43.19M -43.11% | -48.143M -11.47% | -36.755M 23.66% | N/A | |
| EBIT YoY % growth | -11.95M | -21.24M -77.74% | -26.89M -26.60% | -21.45M 20.23% | -36.1M -68.30% | -30.42M 15.73% | -43.41M -42.70% | -48.38M -11.45% | -37.012M 23.50% | N/A -1.97% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -220.00 | -387.20 -76.00% | -363.00 6.25% | -233.20 35.76% | -205.48 11.89% | -94.82 53.85% | -63.58 32.95% | -31.46 50.52% | -19.14 39.16% | N/A 87.37% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.79 77.69% | -0.80 82.78% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -9.588M -0.42% | -9.894M -21.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -4.50 18.18% | -5.00 | 0.50 | 9.96% |
| Q4 2022 Q2Q % growth | -4.62 27.59% | -5.39 | 0.77 | 14.22% |
| Q3 2022 Q2Q % growth | -3.52 42.86% | -4.04 | 0.52 | 12.85% |
| Q2 2022 Q2Q % growth | -5.50 32.43% | -5.95 | 0.45 | 7.51% |
| Q1 2022 Q2Q % growth | -5.50 48.98% | -8.30 | 2.80 | 33.76% |
| Q4 2021 Q2Q % growth | -6.38 -16.00% | -6.43 | 0.05 | 0.82% |
| Q3 2021 Q2Q % growth | -6.16 37.78% | -6.90 | 0.74 | 10.73% |
| Q2 2021 Q2Q % growth | -8.14 70.87% | -8.08 | -0.06 | -0.76% |
| Q1 2021 Q2Q % growth | -10.78 46.74% | -8.08 | -2.70 | -33.44% |
| Q4 2020 Q2Q % growth | -5.50 56.90% | -8.47 | 2.97 | 35.07% |
| Q3 2020 Q2Q % growth | -9.90 56.31% | -9.87 | -0.03 | -0.27% |
| Q2 2020 Q2Q % growth | -27.94 2.31% | -10.88 | -17.06 | -156.72% |
| Q1 2020 Q2Q % growth | -20.24 34.29% | -16.04 | -4.20 | -26.15% |
| Q4 2019 Q2Q % growth | -12.76 | -18.85 | 6.09 | 32.31% |
| Q3 2019 Q2Q % growth | -22.66 | -30.52 | 7.86 | 25.75% |
| Q2 2019 Q2Q % growth | -28.60 | -38.15 | 9.55 | 25.03% |
| Q1 2019 Q2Q % growth | -30.80 | -38.90 | 8.10 | 20.81% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |